Evidence map›Paper›PMID 42649161›Full record

ArticleNature communications2026

Temperature-dependent replication and sensitivity to innate immunity of human coronavirus HKU1.

Julian Buchrieser, Eva Thuillier, Jeanne Postal, Amélie Wileveau, Florence Guivel-Benhassine, Isabelle Staropoli, Nell Saunders, Delphine Planas, Jamie Sugrue, Vincent Bondet and 19 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Julian BuchrieserVirus & Immunity Unit, Institut Pasteur, Université Paris Cité, Paris, France. julian.buchrieser@pasteur.fr.ORCID 0000-0003-4790-7577
Eva Thuillier *Virus & Immunity Unit, Institut Pasteur, Université Paris Cité, Paris, France.
Jeanne Postal *Virus & Immunity Unit, Institut Pasteur, Université Paris Cité, Paris, France.
Amélie Wileveau *Virus & Immunity Unit, Institut Pasteur, Université Paris Cité, Paris, France.ORCID 0009-0005-3850-2924
Florence Guivel-BenhassineVirus & Immunity Unit, Institut Pasteur, Université Paris Cité, Paris, France.
Isabelle StaropoliVirus & Immunity Unit, Institut Pasteur, Université Paris Cité, Paris, France.
Nell SaundersVirus & Immunity Unit, Institut Pasteur, Université Paris Cité, Paris, France.ORCID 0000-0002-0872-1529
Delphine PlanasVirus & Immunity Unit, Institut Pasteur, Université Paris Cité, Paris, France.ORCID 0000-0002-2509-9954
Jamie SugrueTranslational Immunology Unit, Institut Pasteur, Université Paris Cité, Paris, France.
Vincent BondetTranslational Immunology Unit, Institut Pasteur, Université Paris Cité, Paris, France.ORCID 0000-0002-6534-0984
Ignacio FernándezStructural Virology Unit, Institut Pasteur, Université de Paris Cité, CNRS UMR3569, Paris, France.ORCID 0000-0003-2632-8111
François BontemsStructural Virology Unit, Institut Pasteur, Université de Paris Cité, CNRS UMR3569, Paris, France.
Françoise PorrotVirus & Immunity Unit, Institut Pasteur, Université Paris Cité, Paris, France.ORCID 0000-0001-8995-3614
Chloé PetiotVirus & Immunity Unit, Institut Pasteur, Université Paris Cité, Paris, France.
Matthieu ProtEvolutionary Genomics of RNA Viruses Unit, Institut Pasteur, Université Paris Cité, CNRS UMR2000, Paris, France.
Martin Jungbauer-GroznicaVirus & Immunity Unit, Institut Pasteur, Université Paris Cité, Paris, France.
Laurence ArowasInvestigation et volontaires (INVOLvE), Institut Pasteur, Paris, France.
Vincent MichelPathogenesis of Vascular Infections Unit, Institut Pasteur, INSERM, Paris, France.ORCID 0000-0002-7025-4343
Catherine BlancVirology department, Institut Pasteur, Université de Paris Cité, Paris, France.ORCID 0000-0003-4214-1381
Sophie Trouillet-AssantTranslational research unit, Hospices Civils de Lyon, Lyon Sud Hospital, Oullins-Pierre-Bénite, Lyon, France.
Timothée BruelVirus & Immunity Unit, Institut Pasteur, Université Paris Cité, Paris, France.ORCID 0000-0002-3952-4261
Félix A ReyStructural Virology Unit, Institut Pasteur, Université de Paris Cité, CNRS UMR3569, Paris, France.ORCID 0000-0002-9953-7988
Marie-Anne Rameix-WeltiMolecular Mechanisms of Multiplication of Pneumoviruses Unit (M3P), Institut Pasteur, Université Paris-Saclay, Université de Versailles St. Quentin, Université Paris Cité, UMR 1173 (2I), INSERM, Centre National de Reference Virus des Infections Respiratoires (CNR VIR), Assistance Publique des Hôpitaux de Paris, Paris, France.
Nicoletta CasartelliVirus & Immunity Unit, Institut Pasteur, Université Paris Cité, Paris, France.
Arnaud FontanetEmerging Diseases Epidemiology Unit, Institut Pasteur, Université Paris Cité, Paris, France; PACRI Unit, Conservatoire National des Arts et Métiers, Paris, France.
Michael WhiteInfectious Disease Epidemiology and Analytics G5 Unit, Institut Pasteur, Université Paris Cité, INSERM U1347, Paris, France.ORCID 0000-0002-7472-4138
Darragh DuffyTranslational Immunology Unit, Institut Pasteur, Université Paris Cité, Paris, France.ORCID 0000-0002-8875-2308
Etienne Simon-LorièreEvolutionary Genomics of RNA Viruses Unit, Institut Pasteur, Université Paris Cité, CNRS UMR2000, Paris, France.ORCID 0000-0001-8420-7743
Olivier SchwartzVirus & Immunity Unit, Institut Pasteur, Université Paris Cité, Paris, France. olivier.schwartz@pasteur.fr.ORCID 0000-0002-0729-1475

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human coronavirus HKU1, causing common colds and occasionally severe illness, remains largely uncharacterized because it has not been successfully grown on immortalized cells. Here, we identify Caco2 cells overexpressing TMPRSS2, the HKU1 receptor, as being highly permissive to infection. HKU1 replicates efficiently, forms syncytia and releases infectious progeny in these cells at 33 °C, the temperature of the nasal cavity, but is attenuated at 37 °C. Viral entry occurs similarly at both temperatures, but subsequent viral RNA synthesis is enhanced at 33 °C. Released virions display higher stability at 33 °C. In Caco2 and primary epithelial nasal cells, HKU1 is sensitive to interferons (IFN), but induction of IFN stimulated genes, such as IFN-Induced Transmembrane Proteins (IFITMs), is delayed at 33 °C. Once expressed, IFITMs comparably inhibit HKU1 fusion at both temperatures. In contrast, SARS-CoV-2 robustly replicates at 37 °C. Thus, cellular permissiveness, innate immunity and viral properties collectively explain why HKU1 replicates more efficiently at nasal temperature. Our results highlight temperature-sensitivity disparities between coronaviruses, likely associated to different pathogenic outcomes.

Indexed as

CoronavirusImmunity, InnateVirus ReplicationAnimalsCaco-2 CellsCOVID-19Epithelial CellsHumansInterferonsRNA, ViralSARS-CoV-2Serine EndopeptidasesTemperatureVirus InternalizationInterferonsRNA, ViralSerine EndopeptidasesTMPRSS2 protein, human

Identifiers

PMID42649161
PMCPMC13518878

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.